Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Loss of Multimerin-2 and EMILIN-2 Expression in Gastric Cancer Associate with Altered Angiogenesis.

Andreuzzi E, Capuano A, Pellicani R, Poletto E, Doliana R, Maiero S, Fornasarig M, Magris R, Colombatti A, Cannizzaro R, Spessotto P, Mongiat M.

Int J Mol Sci. 2018 Dec 11;19(12). pii: E3983. doi: 10.3390/ijms19123983.

2.

Integrin binding site within the gC1q domain orchestrates EMILIN-1-induced lymphangiogenesis.

Capuano A, Pivetta E, Baldissera F, Bosisio G, Wassermann B, Bucciotti F, Colombatti A, Sabatelli P, Doliana R, Spessotto P.

Matrix Biol. 2018 Oct 26. pii: S0945-053X(18)30344-5. doi: 10.1016/j.matbio.2018.10.006. [Epub ahead of print]

3.

CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.

Casagrande N, Borghese C, Visser L, Mongiat M, Colombatti A, Aldinucci D.

Haematologica. 2019 Mar;104(3):564-575. doi: 10.3324/haematol.2018.196725. Epub 2018 Oct 11.

4.

Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models.

Turetta M, Ben FD, Brisotto G, Biscontin E, Bulfoni M, Cesselli D, Colombatti A, Scoles G, Gigli G, Del Mercato LL.

Curr Med Chem. 2018;25(35):4616-4637. doi: 10.2174/0929867325666180605122633. Review.

5.

The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth.

Paulitti A, Andreuzzi E, Bizzotto D, Pellicani R, Tarticchio G, Marastoni S, Pastrello C, Jurisica I, Ligresti G, Bucciotti F, Doliana R, Colladel R, Braghetta P, Poletto E, Di Silvestre A, Bressan G, Colombatti A, Bonaldo P, Mongiat M.

Oncogene. 2018 Jun;37(25):3399-3414. doi: 10.1038/s41388-017-0107-x. Epub 2018 Feb 27.

PMID:
29483644
6.

Intensive insulin therapy increases glutathione synthesis rate in surgical ICU patients with stress hyperglycemia.

Biolo G, Massolino B, Di Girolamo FG, Fiotti N, Mearelli F, Mazzucco S, Bertuzzi C, Lazzarini R, Colombatti A, De Cicco M.

PLoS One. 2018 Jan 4;13(1):e0190291. doi: 10.1371/journal.pone.0190291. eCollection 2018.

7.

The α4β1/EMILIN1 interaction discloses a novel and unique integrin-ligand type of engagement.

Capuano A, Fogolari F, Bucciotti F, Spessotto P, Nicolosi PA, Mucignat MT, Cervi M, Esposito G, Colombatti A, Doliana R.

Matrix Biol. 2018 Mar;66:50-66. doi: 10.1016/j.matbio.2017.10.001. Epub 2017 Oct 14.

PMID:
29037761
8.

Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.

Borghese C, Casagrande N, Pivetta E, Colombatti A, Boccellino M, Amler E, Normanno N, Caraglia M, De Rosa G, Aldinucci D.

Oncotarget. 2017 Jun 27;8(26):42926-42938. doi: 10.18632/oncotarget.17216.

9.

The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis.

Andreuzzi E, Colladel R, Pellicani R, Tarticchio G, Cannizzaro R, Spessotto P, Bussolati B, Brossa A, De Paoli P, Canzonieri V, Iozzo RV, Colombatti A, Mongiat M.

Matrix Biol. 2017 Dec;64:40-53. doi: 10.1016/j.matbio.2017.04.002. Epub 2017 Apr 21.

PMID:
28435016
10.

The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth.

Modica TME, Maiorani O, Sartori G, Pivetta E, Doliana R, Capuano A, Colombatti A, Spessotto P.

Oncotarget. 2017 Apr 18;8(16):27034-27046. doi: 10.18632/oncotarget.15067.

11.

Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity.

Maiorani O, Pivetta E, Capuano A, Modica TM, Wassermann B, Bucciotti F, Colombatti A, Doliana R, Spessotto P.

Sci Rep. 2017 Jan 11;7:39974. doi: 10.1038/srep39974.

12.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Dec 22;7(12):e2526. doi: 10.1038/cddis.2016.448. No abstract available.

13.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Sep 22;7(9):e2374. doi: 10.1038/cddis.2016.278. Erratum in: Cell Death Dis. 2016 Dec 22;7(12 ):e2526.

14.

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.

Zucchetto A, Tissino E, Hartmann TN, Chigaev A, Del Poeta G, Colombatti A, Gattei V.

Clin Cancer Res. 2016 Jul 1;22(13):3410-1. doi: 10.1158/1078-0432.CCR-16-0050. No abstract available.

15.

Clinical-grade quality platelet-rich plasma releasate (PRP-R/SRGF) from CaCl2 -activated platelet concentrates promoted expansion of mesenchymal stromal cells.

Borghese C, Agostini F, Durante C, Colombatti A, Mazzucato M, Aldinucci D.

Vox Sang. 2016 Aug;111(2):197-205. doi: 10.1111/vox.12405. Epub 2016 Apr 14.

PMID:
27077937
16.

Targeting of EMILIN-1 and EMILIN-2 to Fibrillin Microfibrils Facilitates their Incorporation into the Extracellular Matrix.

Schiavinato A, Keene DR, Wohl AP, Corallo D, Colombatti A, Wagener R, Paulsson M, Bonaldo P, Sengle G.

J Invest Dermatol. 2016 Jun;136(6):1150-1160. doi: 10.1016/j.jid.2016.02.021. Epub 2016 Mar 2.

17.

Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.

Pivetta E, Wassermann B, Del Bel Belluz L, Danussi C, Modica TM, Maiorani O, Bosisio G, Boccardo F, Canzonieri V, Colombatti A, Spessotto P.

Clin Sci (Lond). 2016 Jul 1;130(14):1221-36. doi: 10.1042/CS20160064. Epub 2016 Feb 26.

18.

MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth.

Colladel R, Pellicani R, Andreuzzi E, Paulitti A, Tarticchio G, Todaro F, Colombatti A, Mongiat M.

Oncotarget. 2016 Jan 12;7(2):2022-37. doi: 10.18632/oncotarget.6515.

19.

Diagnostic Exome Sequencing Identifies a Novel Gene, EMILIN1, Associated with Autosomal-Dominant Hereditary Connective Tissue Disease.

Capuano A, Bucciotti F, Farwell KD, Tippin Davis B, Mroske C, Hulick PJ, Weissman SM, Gao Q, Spessotto P, Colombatti A, Doliana R.

Hum Mutat. 2016 Jan;37(1):84-97. doi: 10.1002/humu.22920. Epub 2015 Nov 4.

20.

SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Lovisa S, Citro S, Sonego M, Dall'Acqua A, Ranzuglia V, Berton S, Colombatti A, Belletti B, Chiocca S, Schiappacassi M, Baldassarre G.

J Mol Cell Biol. 2016 Feb;8(1):17-30. doi: 10.1093/jmcb/mjv056. Epub 2015 Oct 8.

21.

Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender.

Pivetta E, Wassermann B, Bulian P, Steffan A, Colombatti A, Polesel J, Spessotto P.

Oncotarget. 2015 Oct 13;6(31):31889-900. doi: 10.18632/oncotarget.5575.

22.

SERS analysis of serum for detection of early and locally advanced breast cancer.

Cervo S, Mansutti E, Del Mistro G, Spizzo R, Colombatti A, Steffan A, Sergo V, Bonifacio A.

Anal Bioanal Chem. 2015 Sep;407(24):7503-9. doi: 10.1007/s00216-015-8923-8. Epub 2015 Aug 9.

PMID:
26255294
23.

Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.

Celegato M, Borghese C, Casagrande N, Mongiat M, Kahle XU, Paulitti A, Spina M, Colombatti A, Aldinucci D.

Blood. 2015 Sep 10;126(11):1394-7. doi: 10.1182/blood-2015-07-660365. Epub 2015 Jul 30. No abstract available.

24.

Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.

Del Mistro G, Cervo S, Mansutti E, Spizzo R, Colombatti A, Belmonte P, Zucconelli R, Steffan A, Sergo V, Bonifacio A.

Anal Bioanal Chem. 2015 May;407(12):3271-5. doi: 10.1007/s00216-015-8610-9. Epub 2015 Mar 20.

PMID:
25791298
25.

In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Veljkovic V, Glisic S, Muller CP, Scotch M, Branch DR, Perovic VR, Sencanski M, Veljkovic N, Colombatti A.

Front Microbiol. 2015 Feb 19;6:135. doi: 10.3389/fmicb.2015.00135. eCollection 2015.

26.

Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.

Berton S, Pellizzari I, Fabris L, D'Andrea S, Segatto I, Canzonieri V, Marconi D, Schiappacassi M, Benevol S, Gattei V, Colombatti A, Belletti B, Baldassarre G.

Cell Cycle. 2014;13(19):3100-11. doi: 10.4161/15384101.2014.949512.

27.

Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains.

Bot S, Andreuzzi E, Capuano A, Schiavinato A, Colombatti A, Doliana R.

Matrix Biol. 2015 Jan;41:44-55. doi: 10.1016/j.matbio.2014.10.001. Epub 2014 Nov 1.

PMID:
25445627
28.

Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.

Casagrande N, Celegato M, Borghese C, Mongiat M, Colombatti A, Aldinucci D.

Clin Cancer Res. 2014 Nov 1;20(21):5496-506. doi: 10.1158/1078-0432.CCR-14-0713. Epub 2014 Sep 17.

29.

Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts.

Celegato M, Fregona D, Mongiat M, Ronconi L, Borghese C, Canzonieri V, Casagrande N, Nardon C, Colombatti A, Aldinucci D.

Future Med Chem. 2014 Jul;6(11):1249-63. doi: 10.4155/fmc.14.81.

PMID:
25162999
30.

Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Nov 12;32(48):6569-75. doi: 10.1016/j.vaccine.2014.07.007. Epub 2014 Jul 19.

PMID:
25045818
31.

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.

Segatto I, Berton S, Sonego M, Massarut S, Perin T, Piccoli E, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Oncotarget. 2014 Aug 15;5(15):6267-79.

32.

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

Oncotarget. 2014 Mar 15;5(5):1185-97.

33.

The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma.

Celegato M, Borghese C, Umezawa K, Casagrande N, Colombatti A, Carbone A, Aldinucci D.

Cancer Lett. 2014 Jul 10;349(1):26-34. doi: 10.1016/j.canlet.2014.03.030. Epub 2014 Apr 2.

PMID:
24704296
34.

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.

Segatto I, Berton S, Sonego M, Massarut S, Fabris L, Armenia J, Mileto M, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Mol Oncol. 2014 May;8(3):766-80. doi: 10.1016/j.molonc.2014.02.006. Epub 2014 Mar 12.

35.

The inflammatory chemokine CCL5 and cancer progression.

Aldinucci D, Colombatti A.

Mediators Inflamm. 2014;2014:292376. doi: 10.1155/2014/292376. Epub 2014 Jan 2. Review.

36.

Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1.

Pivetta E, Danussi C, Wassermann B, Modica TM, Del Bel Belluz L, Canzonieri V, Colombatti A, Spessotto P.

Matrix Biol. 2014 Feb;34:22-32. doi: 10.1016/j.matbio.2014.01.018. Epub 2014 Feb 7.

PMID:
24513040
37.

Surface-enhanced Raman spectroscopy of blood plasma and serum using Ag and Au nanoparticles: a systematic study.

Bonifacio A, Dalla Marta S, Spizzo R, Cervo S, Steffan A, Colombatti A, Sergo V.

Anal Bioanal Chem. 2014 Apr;406(9-10):2355-65. doi: 10.1007/s00216-014-7622-1. Epub 2014 Feb 4.

PMID:
24493335
38.

EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration.

Marastoni S, Andreuzzi E, Paulitti A, Colladel R, Pellicani R, Todaro F, Schiavinato A, Bonaldo P, Colombatti A, Mongiat M.

J Pathol. 2014 Mar;232(4):391-404. doi: 10.1002/path.4316.

PMID:
24374807
39.

Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.

Casagrande N, De Paoli M, Celegato M, Borghese C, Mongiat M, Colombatti A, Aldinucci D.

Gynecol Oncol. 2013 Dec;131(3):744-52. doi: 10.1016/j.ygyno.2013.08.041. Epub 2013 Sep 10.

PMID:
24029417
40.

EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance.

Danussi C, Del Bel Belluz L, Pivetta E, Modica TM, Muro A, Wassermann B, Doliana R, Sabatelli P, Colombatti A, Spessotto P.

Mol Cell Biol. 2013 Nov;33(22):4381-94. doi: 10.1128/MCB.00872-13. Epub 2013 Sep 9.

41.

Inhibition of breast cancer local relapse by targeting p70S6 kinase activity.

Segatto I, Berton S, Sonego M, Massarut S, D'Andrea S, Perin T, Fabris L, Armenia J, Rampioni G, Lovisa S, Schiappacassi M, Colombatti A, Bristow RG, Vecchione A, Baldassarre G, Belletti B.

J Mol Cell Biol. 2013 Dec;5(6):428-31. doi: 10.1093/jmcb/mjt027. Epub 2013 Jul 29. No abstract available.

PMID:
23899505
42.

Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts.

Celegato M, Borghese C, Casagrande N, Carbone A, Colombatti A, Aldinucci D.

Leuk Lymphoma. 2014 Jan;55(1):149-59. doi: 10.3109/10428194.2013.800196. Epub 2013 Jun 12.

PMID:
23647062
43.

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

Sonego M, Schiappacassi M, Lovisa S, Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri V, Militello L, Napoli M, Giorda G, Pivetta B, Mezzanzanica D, Barbareschi M, Valeri B, Canevari S, Colombatti A, Belletti B, Del Sal G, Baldassarre G.

EMBO Mol Med. 2013 May;5(5):707-22. doi: 10.1002/emmm.201201504. Epub 2013 Apr 22. Erratum in: EMBO Mol Med. 2014 Feb;6(2):295.

44.

NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.

Cattaruzza S, Nicolosi PA, Braghetta P, Pazzaglia L, Benassi MS, Picci P, Lacrima K, Zanocco D, Rizzo E, Stallcup WB, Colombatti A, Perris R.

J Mol Cell Biol. 2013 Jun;5(3):176-93. doi: 10.1093/jmcb/mjt010. Epub 2013 Apr 3.

45.

Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.

Borghese C, Cattaruzza L, Pivetta E, Normanno N, De Luca A, Mazzucato M, Celegato M, Colombatti A, Aldinucci D.

J Cell Biochem. 2013 May;114(5):1135-44. doi: 10.1002/jcb.24456.

PMID:
23192362
46.

Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.

Cattaruzza S, Ozerdem U, Denzel M, Ranscht B, Bulian P, Cavallaro U, Zanocco D, Colombatti A, Stallcup WB, Perris R.

Angiogenesis. 2013 Apr;16(2):309-27. doi: 10.1007/s10456-012-9316-7. Epub 2012 Nov 4.

47.

Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations.

Silvestri A, Calvert V, Belluco C, Lipsky M, De Maria R, Deng J, Colombatti A, De Marchi F, Nitti D, Mammano E, Liotta L, Petricoin E, Pierobon M.

Clin Exp Metastasis. 2013 Mar;30(3):309-16. doi: 10.1007/s10585-012-9538-5. Epub 2012 Sep 29.

48.

Stathmin is dispensable for tumor onset in mice.

D'Andrea S, Berton S, Segatto I, Fabris L, Canzonieri V, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

PLoS One. 2012;7(9):e45561. doi: 10.1371/journal.pone.0045561. Epub 2012 Sep 20.

49.

An EMILIN1-negative microenvironment promotes tumor cell proliferation and lymph node invasion.

Danussi C, Petrucco A, Wassermann B, Modica TM, Pivetta E, Del Bel Belluz L, Colombatti A, Spessotto P.

Cancer Prev Res (Phila). 2012 Sep;5(9):1131-43. doi: 10.1158/1940-6207.CAPR-12-0076-T. Epub 2012 Jul 24.

50.

Vascular smooth muscle Emilin-1 is a regulator of arteriolar myogenic response and blood pressure.

Litteri G, Carnevale D, D'Urso A, Cifelli G, Braghetta P, Damato A, Bizzotto D, Landolfi A, Ros FD, Sabatelli P, Facchinello N, Maffei A, Volpin D, Colombatti A, Bressan GM, Lembo G.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2178-84. doi: 10.1161/ATVBAHA.112.254664. Epub 2012 Jul 19.

PMID:
22814752

Supplemental Content

Loading ...
Support Center